BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Bogdana Schmidt
55%, which is, you're absolutely right. The durability is where it counts, right? That 83% number, that response at any point, that's great. We're all excited. But if at three months it looks great and at six months it's all back, then that wouldn't really help the patient. That just cost him a lot of money.
0
💬
0
Comments
Log in to comment.
There are no comments yet.